Valuation : Terumo Corporation

Market Cap 3,346B 21.78B 18.75B 17.65B 16.08B 30.09B 2,073B 30.21B 209B 80.85B 1,056B 81.8B 80.02B P/E 2027 *
16.9x
P/E 2028 * 17.4x
Enterprise Value 3,392B 22.08B 19B 17.89B 16.3B 30.5B 2,101B 30.63B 212B 81.96B 1,071B 82.92B 81.12B EV / Sales 2027 *
2.69x
EV / Sales 2028 * 2.48x
Free-Float
97.07%
Yield 2027 *
1.64%
Yield 2028 * 1.79%
1 day-1.46%
1 week-9.42%
Current month-11.17%
1 month-13.22%
3 months-3.18%
6 months+9.40%
Current year-1.54%
1 week 2,200
Extreme 2200
2,463.5
1 month 2,200
Extreme 2200
2,689
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.46%-9.42%-13.71%+4.34% 21.78B
-0.27%-4.74%-20.25%+4.47% 182B
-0.54%-0.31%-2.32%+14.92% 118B
-0.42%-3.88%+8.25%+81.95% 61.7B
-0.32%-5.42%+11.66%+43.87% 50.55B
+0.39%-4.12%-5.61%-32.60% 48.98B
-0.77%-6.48%+6.99%-19.62% 31.65B
-1.84%-6.20% - - 29.87B
-0.24%-1.66%+33.69%-14.30% 23.71B
+0.16%-4.03%+9.10%-26.92% 21.55B
Average -0.55%-3.99%+3.09%+6.24% 58.94B
Weighted average by Cap. -0.43%-3.02%-3.96%+12.15%

Financials

2027 *2028 *
Net sales 1,259B 8.2B 7.05B 6.64B 6.05B 11.32B 780B 11.37B 78.7B 30.42B 397B 30.78B 30.11B 1,339B 8.72B 7.5B 7.06B 6.44B 12.04B 830B 12.09B 83.72B 32.36B 423B 32.74B 32.02B
Net income 195B 1.27B 1.09B 1.03B 937M 1.75B 121B 1.76B 12.19B 4.71B 61.53B 4.77B 4.66B 192B 1.25B 1.07B 1.01B 922M 1.73B 119B 1.73B 12B 4.64B 60.56B 4.69B 4.59B
Net Debt 45.99B 299M 258M 243M 221M 414M 28.5B 415M 2.88B 1.11B 14.52B 1.12B 1.1B -26.39B -172M -148M -139M -127M -237M -16.35B -238M -1.65B -638M -8.33B -645M -631M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
10/09/26 ¥2,235.00 -1.46% 5,919,800
09/09/26 ¥2,268.00 -2.51% 5,631,200
08/09/26 ¥2,326.50 -1.98% 3,938,300
07/09/26 ¥2,373.50 -2.41% 4,321,600
04/09/26 ¥2,432.00 -1.44% 3,436,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,268.00JPY
Average target price
3,140.77JPY
Spread / Average Target
+38.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!